#	Pagina
attuale pagina	/open-h2020/projects/206290/index.html
-1	/open-h2020/projects/215077/index.html
-2	/open-h2020/projects/223240/index.html
-3	/open-h2020/projects/195587/index.html
-4	/open-consip/fornitori/2020/profilo-01965310921/index.html
-5	/open-h2020/projects/195879/index.html
-6	/open-h2020/per-topic/transferrable/list/index.html
-7	/open-h2020/per-topic/ei30/list/index.html
-8	/open-h2020/per-topic/edda/list/index.html
-9	/open-h2020/per-topic/rendition/list/index.html
-10	/open-h2020/per-topic/il/list/index.html

Opendata, web and dolomites

MMpredict SIGNED

Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

MMpredict project word cloud

Explore the words cloud of the MMpredict project. It provides you a very rough idea of what is the project "MMpredict" about.

cancer ivd myeloma expression quality survival consists intrinsic expanded heterogeneity organisation microarray 2 blood economic treatment assay prognosis life renaming commercialise urgent world filed cancers complicates previously gene respectively 1 effectiveness centres profiling gt individual unmet diagnostics diagnostic predicts renowned multiple registration science reliably treatments healthcare mmpredictor medicine personalised positioning prediction supports predict mmprofiler outcome suitable 15 successfully molecular outcomes combining market prevent trial clinical options vitro patients advocacy 5 annually error strategies subtype strategy tool mm patient addendum reduce complementary skylinedx health decision intended sme specialised form variability kols deaths expertise tumour

Project "MMpredict" data sheet

The following table provides information about the project.

Coordinator	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM Organization address address: DR MOLEWATERPLEIN 40 city: ROTTERDAM postcode: 3015 GD website: www.erasmusmc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Project website	http://www.mmh2020.eu/
Total cost	3˙755˙802 €
EC max contribution	2˙949˙027 € (79%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2. (PRIORITY 'Industrial leadership')
Code Call	H2020-FTIPilot-2015-1
Funding Scheme	IA
Starting year	2016
Duration (year-month-day)	from 2016-11-01 to 2020-04-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM Organization address address: DR MOLEWATERPLEIN 40 city: ROTTERDAM postcode: 3015 GD website: www.erasmusmc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (ROTTERDAM)	coordinator	419˙687.00
2	SKYLINEDX B.V. SKYLINEDX B.V. Organization address address: LICHTENAUERLAAN 40 city: ROTTERDAM postcode: 3062 ME website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (ROTTERDAM)	participant	1˙882˙475.00
3	UNIVERSITA DEGLI STUDI DI TORINO UNIVERSITA DEGLI STUDI DI TORINO Organization address address: VIA GIUSEPPE VERDI 8 city: TORINO postcode: 10124 website: www.unito.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (TORINO)	participant	387˙500.00
4	ERASMUS UNIVERSITEIT ROTTERDAM ERASMUS UNIVERSITEIT ROTTERDAM Organization address address: BURGEMEESTER OUDLAAN 50 city: ROTTERDAM postcode: 3062 PA website: www.eur.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (ROTTERDAM)	participant	210˙615.00
5	MYELOMA PATIENTS EUROPE AISBL MYELOMA PATIENTS EUROPE AISBL Organization address address: RUE DE DAMPREMY 67 BTE 32 city: Charleroi postcode: 6000 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (Charleroi)	participant	48˙750.00

Map

Project objective

The consortium aims to commercialise the MMpredictor as a personalised medicine tool that predicts the most effective treatment strategy for individual Multiple Myeloma (MM) patients. MM is the second most common form of blood cancer contributing to 15% of all blood cancers and ~1,5% and 2% of all cancer deaths annually in the EU and US, respectively. Patients show a large variability in treatment response and side effects due to tumour heterogeneity and the patient’s intrinsic characteristics. Therefore, not every treatment will be suitable for each patient, and treatment strategies are often based on trial-and-error. The availability of multiple (>20) treatment options complicates treatment decision-making even more. With the current development of many more promising treatments, there is an urgent unmet clinical need for a diagnostic assay that supports personalised cancer treatment in order to improve patient health outcomes, prevent side effects and reduce healthcare costs. SkylineDx has previously developed the MMprofiler, a microarray-based diagnostic test that can subtype MM patients and reliably predict MM patient survival (prognosis). In this project, the test’s clinical value will be expanded to include the prediction of treatment effectiveness in individual patients based on Gene Expression Profiling. An addendum for new intended use will be filed to the current in vitro diagnostic (IVD) registration, while renaming the test to MMpredictor. The project will also focus on positioning the test as a cost-effective IVD test for personalised medicine, that will increase health outcome and quality of life of patients and reduce healthcare costs. The consortium consists of a life science SME specialised in molecular diagnostics, clinical centres with world renowned KOLs, a leading health economic institute, and a European MM patient advocacy organisation combining all the required complementary expertise to successfully bring the MMpredictor to market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MMPREDICT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MMPREDICT" are provided by the European Opendata Portal: CORDIS opendata.